Abstract
To determine the degree of influence of the confounders on the outcome of ischemic stroke (IS). One hundred and eight patients were included in the prospective clinical cohort study. Based on disease outcomes, two groups of patients were singled out: 1st group - survivors (n=93), 2nd group - patients with fatal outcomes (n=15). Concomitant diseases were found in 80 (74.1%) patients. Twenty-eight (25.9%) patients had no concomitant pathology (without taking into account atherosclerosis, arterial hypertension, diabetes mellitus and coronary heart disease). The Pearson χ2 test was 0.005 (p=0.944), which indicated that there was no significant association between the fatal outcome and the presence of confounders. The relative risk (RR) was 0.963 (95% CI 0.333-2.779), indicating that the likelihood of a favorable or fatal outcome was almost equal. Therefore, the presence or absence of confounders noted in patients of our cohort does not affect the likelihood of a favorable or fatal outcome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
